Functional characteristics of novel pancreatic Pax6 regulatory elements by Buckle, Adam et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Functional characteristics of novel pancreatic Pax6 regulatory
elements
Citation for published version:
Buckle, A, Nozawa, R-S, Kleinjan, DA & Gilbert, N 2018, 'Functional characteristics of novel pancreatic
Pax6 regulatory elements' Human Molecular Genetics. DOI: 10.1093/hmg/ddy255
Digital Object Identifier (DOI):
10.1093/hmg/ddy255
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Human Molecular Genetics
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 08. Jul. 2019
  1
Functional characteristics of novel pancreatic Pax6 regulatory elements 1 
 2 
Adam Buckle1, Ryu-suke Nozawa1, Dirk A. Kleinjan2*, Nick Gilbert1* 3 
 4 
1MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe 5 
Rd, Edinburgh, EH4 2XR, UK 6 
2Centre for Mammalian Synthetic Biology, University of Edinburgh, Kings buildings, Edinburgh, EH9 3FF, 7 
UK 8 
 9 
Correspondence: 10 
DA Kleinjan 11 
E-mail: dirk-jan.kleinjan@ed.ac.uk 12 
N Gilbert 13 
Tel: +441316518551; Fax: +441316518800; E-mail: nick.gilbert@ed.ac.uk 14 
 15 
Abstract 16 
Complex diseases, such as diabetes, are influenced by comprehensive transcriptional networks. Genome-17 
wide association studies have revealed that variants located in regulatory elements for pancreatic 18 
transcription factors are linked to diabetes, including those functionally linked to the paired box 19 
transcription factor, Pax6. Pax6 deletions in adult mice cause rapid onset of classic diabetes, but the full 20 
spectrum of pancreatic Pax6 regulators is unknown. Using a regulatory element discovery approach we 21 
identified two novel Pax6 pancreatic cis-regulatory elements in a poorly characterised regulatory desert. 22 
Both new elements, PE3 and PE4, are located 50 and 100 kb upstream, interact with different parts of the 23 
Pax6 promoter and nearby non-coding RNAs. They drive expression in the developing pancreas and brain, 24 
and code for multiple pancreas related transcription factor binding sites. PE3 binds CTCF and is marked by 25 
stem cell identity markers in embryonic stem cells, whilst a common variant located in the PE4 element 26 
affects binding of Pax4, a known pancreatic regulatory, altering Pax6 gene expression. To determine the 27 
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ability of these elements to regulate gene expression synthetic transcriptional activators and repressors were 28 
targeted to PE3 and PE4, modulating Pax6 gene expression, as well as influencing neighbouring genes and 29 
lncRNAs, implicating the Pax6 locus in pancreas function and diabetes. 30 
  31 
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Introduction 32 
Distal cis-regulatory elements are a major component of the mechanism asserting temporal and spatial 33 
patterns of gene expression. Understanding the function of regulatory elements has taken on new 34 
significance as they are increasingly linked to human phenotypic variation and complex disease phenotypes. 35 
However as approximately 90% of disease-associated risk alleles fall within non-coding regions, a major 36 
challenge is pinpointing target genes and understanding underlying mechanisms of dysregulation (1).  37 
Pax6 is an evolutionarily conserved pleiotropic transcription factor with roles in development of the central 38 
nervous system (CNS), the eye, the olfactory system and is also critical for pancreas development and 39 
hormone production from endocrine secretory cells (2, 3). In humans the congenital eye malformation 40 
aniridia is characterized by haploinsufficiency for the PAX6 protein  and studying this condition has enabled 41 
the identification of large cis-regulatory regions controlling Pax6 expression (4).  In the pancreas multiple 42 
complex transcriptional networks utilise homeo- and paired-domain-containing transcription factors (such 43 
as Nkx2.2, Nkx6.1, Pdx1, Pax4, Isl1, and Pax6) (5) which are vital for coordinating the differentiation of 44 
progenitors to mature pancreatic cells (6) and directly regulate many pancreatic target genes (5, 7). Pax4 is 45 
another well-studied pancreatic transcription factor and is expressed early in pancreas development, where 46 
it is essential for specification and maintenance, as mice null for Pax4 have a severe diabetic phenotype (8). 47 
Pax4 is also important for adult β-cell function and is linked to human pancreatic disease; mutations and 48 
common risk alleles in Pax4 have been linked to Type1 diabetes (T1D) and Type 2 diabetes T2D (9–11). 49 
Diabetes is caused by loss or dysfunction of the insulin secreting pancreatic -cells, with autoimmune loss 50 
causing T1D, while in T2D Insulin secretion is defective, which in turn brings about an imbalance in glucose 51 
homeostasis and insulin resistance (9). Pax6 is required for embryonic stem cell differentiation to neural 52 
lineages consistent with its critical role in neural development. It is also expressed in the early pancreatic 53 
bud and is necessary for insulin homeostasis in the adult pancreas (12, 13); Pax6 deletion rapidly leads to 54 
classical diabetes and weight loss (13). A common regulatory variant (rs11603334G>A) for fasting pro-55 
insulin levels (14, 15) is located in the ARAP1 promoter, a regulator of PAX6 whilst a genome-wide 56 
association to BMI (p ≤ 5.0×10-7) is found upstream of the PAX6 gene (16). Consistently a study of aniridia 57 
patients with heterozygous PAX6 mutation found glucose intolerance characterized by impaired insulin 58 
secretion in all patients, demonstrating the endocrine pancreas is sensitive to levels of PAX6 (17). Similarly 59 
genome wide profiling of cis-regulatory networks in islet cells have shown an enrichment of T2D SNPs in 60 
islet specific enhancers, which themselves bind islet transcription factors (18).   61 
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Within the 11p13 locus the most critical gene encodes PAX6, which has a large regulatory domain with 62 
multiple long range elements, many of which reside within introns of its neighbouring gene, ELP4, including 63 
the downstream regulatory region (DRR), a complex enhancer cluster of tissue specific hypersensitive sites 64 
(19) (Figure 1A). Of importance for pancreatic function the pancreas and ectoderm enhancer cluster (P/EE) 65 
drives α and β-cell specific expression during development and after birth (20) and a pancreas-specific 66 
regulatory element (PE2) that drives stable endocrine pancreas expression during development and into 67 
adulthood (21). Targeted deletions of P/EE and PE2 regions reduce Pax6 expression in the pancreas (22), 68 
but do not abolish it, we therefore hypothesised that other, as yet unidentified, pancreas-specific Pax6 69 
regulatory elements exist, and would be functionally conserved between human and mouse and reveal novel 70 
insight into Pax6 pancreatic function and regulation.  71 
To identify and functionally characterize novel regulatory elements in the PAX6 regulatory domain we 72 
analysed human pancreatic tissues, mouse pancreatic β-cells (β-TC3) and ES cells as tractable experimental 73 
systems. Two elements were identified that associated with chromatin marks indicative of regulatory 74 
function in human and mouse pancreatic cells, called PE3 and PE4, they acted as regulatory elements in 75 
mouse reporter transgenics, revealing a neural and pancreatic expression pattern. Functional 76 
characterization of PE3 showed it was bound by CTCF and engaged the Pax6 gene via regulatory looping 77 
over a 50 kb region, in both pancreatic cells and in mouse embryonic stem cells (mESC), whilst PE4 showed 78 
a more complex interaction profile in pancreatic cells interacting with PE3, the Paupar lncRNA and the 79 
Pax6 gene. Within the PE4 element, a common variant, rs7943160G>C, is positioned in a vertebrate 80 
conserved PAX4 binding motif, and alters reporter expression in a PAX4 dependent manner, linking two 81 
pancreatic transcription factors. Finally, we demonstrated the importance of these cis regulatory sites by 82 
recruiting transcription activator-like (TAL) effectors fused to transactivator or repressor domains to the 83 
PE3 and PE4 elements to modulate expression of PAX6 and surrounding genes.  84 
Results 85 
Identification of novel human and mouse conserved pancreatic regulatory elements  86 
In contrast to the downstream region of PAX6, which has a significant role in disease aetiology of aniridia 87 
patients, the upstream region towards RCN1 is less well studied; it only includes the E-200 element and E-88 
55 cluster, implicating this region as a regulatory “desert” even though it is known to contain a number of 89 
evolutionarily conserved sites (23, 24). As cis regulatory elements  are key for modulation of gene expression 90 
through transcription factor binding, and are increasingly linked to complex disease phenotypes, we set out 91 
Downloaded from https://academic.oup.com/hmg/advance-article-abstract/doi/10.1093/hmg/ddy255/5052132
by Edinburgh University user
on 16 July 2018
  5
to identify and characterise novel PAX6 regulatory elements specific for pancreatic expression, due to its 92 
roles in pancreatic development and T2D. Reasoning that novel regulatory elements would be marked by 93 
enhancer specific histone modifications, we mined histone H3K27ac and H3K4me1 ChIP data sets from 94 
human primary pancreatic islet tissue (Human Epigenome atlas). Analysis of the region upstream of the 95 
PAX6 gene suggested it might harbour a number of putative PAX6 regulatory elements. Peak calling was 96 
used to identify pronounced ChIP signal enrichment, marking 5 discrete peaks in the upstream region 97 
(Figure 1B), labelled A-E, as putative novel cis regulatory elements. Analysis of transcriptome data from 98 
primary purified human pancreatic beta cells (25), confirmed high PAX6 expression but unexpectedly two 99 
long noncoding RNAs (lncRNAs), PAUPAR and PAX6-AS1, located upstream of Pax6 were also expressed 100 
in β-cells (Fig 1B).  Quantification across 6 individual primary β-cells (Table S1) indicated that PAUPAR was 101 
consistently expressed (mean FPKM 5.7) and aligned with the islet H3K27ac signal. The second lncRNA 102 
PAX6-AS1 is analogous to mouse Pax6OS1 (26) (mean FPKM 10.2) and together this expression data 103 
suggests that PAX6 locus lncRNAs may have a role in pancreatic cells. 104 
Although this data hinted at the presence of regulatory elements, H3K27ac enrichment alone is not definitive 105 
for their identification. Important regulatory elements are likely to be well conserved in sequence and 106 
function between mammalian species, so putative regulatory marks in mouse cells were investigated. The 107 
strict tissue specificity of Pax6 expression requires that ChIP enhancer profiling must be performed in a 108 
suitable cell type to identify appropriate active regulatory elements. Few pancreatic β-cell lines are available 109 
but mouse pancreatic β-TC3 are used in many studies and  express Pax6 at a high level (27), so provide a 110 
suitable model. ChIP-on-chip for the active enhancer modification H3K27ac was performed and mapped 111 
across the Pax6 region using custom tiling arrays in β-TC3 cells (Fig 1C). The H3K27ac modification marked 112 
the Pax6 promoter region and promoters of the adjacent ubiquitously expressed genes, Elp4, Immpl1 and 113 
Rcn1. H3K27ac enrichment extended beyond the Pax6 promoters, upstream where known Pax6 pancreatic 114 
elements P/EE and PE2 are located and over the Pax6 intron 7 enhancer cluster, 7CE1-4. Strikingly the 115 
mouse β-TC3 H3K27ac signal showed multiple novel H3K27ac enriched regions in the Pax6 upstream 116 
region (labelled elements E-52, E-95, and E-120; 52kb, 95kb and 120kb 5’ from the mouse P0 promoter 117 
respectively). There was high concordance between the β-TC3 and the human pancreatic islet data; human 118 
H3K27ac peaks A and B share core sequences with the mouse H3K27ac peaks E-52 and E-120. Previously, 119 
only the P/EE and PE2 elements were characterized as PAX6 pancreatic enhancers (20–22); thus 120 
identification of these new elements significantly expands the repertoire of regulatory regions with a 121 
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potential role in controlling PAX6 expression in the pancreas. High resolution analysis of mouse and human 122 
DNaseI ENCODE data confirmed that these elements were discrete (data not shown), so were named as 123 
putative cis-regulatory Pancreatic Element 3 (PE3; corresponding to human peak A and mouse E-52), and 124 
PE4 (corresponding to human peak B and mouse E-120) (Fig 1).  125 
We hypothesized that gene expression patterns as well as cis regulatory elements would be conserved 126 
between mouse and human pancreatic cells, so RNA-seq in β-TC3 cells was performed (Fig 1B). This 127 
revealed high Pax6 (mean FPKM 110) and Paupar and Pax6Os1 lncRNA (mean FPKM 2.2 and 6.2) 128 
expression (Table1), as seen in human pancreatic samples. To further assess the cell type specificity of these 129 
putative elements, we analysed Epigenome Atlas H3K4me1 ChIP-seq data across 48 distinct human tissues 130 
(Fig S1). There was visible enrichment of H3K4me1 signal over the PE3 region in 45% of tissues assayed, 131 
while PE4 only showed enrichment in pancreatic islet tissue samples (PI_13 and PI_27), suggesting it was 132 
pancreas-specific.  133 
PE3 and PE4 elements transactivate expression in mouse reporter transgenics 134 
To assess the spatio-temporal characteristics of the novel PE3 and PE4 regulatory elements we generated 135 
LacZ reporter transgenic mice (20, 21). The putative regulatory elements were cloned into a Hsp68 minimal 136 
promoter–LacZ reporter construct (4) and used to generate transient transgenic embryos and stable lines, 137 
that were analysed at different developmental stages (Fig S2, Figure 2). For the PE3 element, 6 independent 138 
E11.5 dpc transient transgenic embryos were analysed before obtaining two stable lines, one of which was 139 
studied in detail across multiple developmental stages. Consistent staining between transient embryos and 140 
stable lines was observed in regions of the pancreas, brain and neural tube (Figure 2A-D). Midbrain 141 
expression was consistently observed for the PE3 element which is not a site of Pax6 expression, however 142 
such occurrences of ectopic expression sites are not unusual in reporter transgenics when the element is not 143 
in its correct genomic context (28). 144 
At E10.5 the PE3 element showed staining in the pancreas primordium, parts of the CNS including along 145 
the neural tube in the basal plate and dorsal root ganglia, as well as in the ventral midbrain and hindbrain 146 
(Fig 2A, B). At E11.5 staining was visible in the midbrain and hindbrain, whilst opening up the body cavity 147 
revealed further pancreatic staining (Fig 2C,D). During later stages of development expression became 148 
restricted to specific regions of the CNS, in particular the lateral olfactory tracts, midbrain, cerebellum and 149 
regions of the hindbrain (Figure S2A, B).  150 
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For the PE4 element three stable lines were obtained and consistent expression observed in a more restricted 151 
manner in the pancreas and specific regions of the developing brain. The PE4 element showed a more diffuse 152 
staining pattern in the CNS at E11.5 (Fig 2E), but some staining could be seen in the centre of the pancreas 153 
primordium (Fig 2F). At E17.5 the pancreas showed strong staining in islet like cells (Fig 2G), consistent with 154 
the reported Pax6 expression pattern (29). Also at E17.5 the lateral olfactory tract, cerebellum and focal 155 
regions of the hindbrain showed expression (Fig 2H, Fig 2C). 156 
These results support PE3 and PE4 to be novel tissue-specific regulators driving reporter expression in 157 
embryonic pancreas and neuronal tissues. PE3 has a broad Pax6 expression pattern across multiple stages of 158 
development, while PE4 is more restricted to the developing pancreas.  159 
Novel Pax6 regulatory elements show sequence conservation, transcription factor binding and encode 160 
putative regulatory SNPs 161 
To directly compare between the human and mouse locus, sequence conservation at the putative PE3 and 162 
PE4 elements along with conserved transcription factor binding motifs within their sequences was examined 163 
to identify pathways and potential regulators. The PE3 element contained a 474 bp block with 58% sequence 164 
identity between human and mouse (Fig S3A), with a fully conserved 38 bp core across multiple mammalian 165 
species (data not shown). Transcription factor binding motifs were identified within the element for the Sox 166 
and Oct genes (30). Gene expression analysis of these transcription factors using the Human Protein atlas 167 
(31), revealed that 9 were expressed (FPKM >1) in adult pancreas, suggesting they are candidate transcription 168 
factors for binding to this element (Table S2). Based on identification of pluripotency motifs we next 169 
investigated published ChIP-seq data over the Pax6 region in mESC and noted that the PE3 element and 170 
neighbouring E-55 elements were associated with active H3K27ac and H3K4me1 enhancer modifications, 171 
the p300 transcriptional co-activator as well as pluripotent transcription factors Sox2, Oct4 and Nanog (Fig 172 
3A) (32). Sox2 and Oct4 have been shown to bind the Pax6 promoter in mESC and displace nucleosomes 173 
over the region (33). Consistently, Pax6 is one of a group of transcription factors which are bivalently marked 174 
in ESC by H3K4me3/H3k27me3 ready for activation upon differentiation (34). In addition to these 175 
pluripotency factors sequence analysis using the CTCF binding Site Database prediction tool (35) identified 176 
a conserved CTCF binding site in PE3 (Fig S3A) and ChIP in mouse β-TC3 cells confirmed this site binds 177 
CTCF in vivo (Fig S3B). Together this data revealed PE3 is a novel distal site of active transcriptional 178 
regulation of Pax6 in mESC, which binds important pluripotency transcription factors and is occupied by a 179 
key regulator of 3D chromatin organisation (36). 180 
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Alignment of human and mouse sequences for the PE4 element identified a 802 bp fragment with 74% 181 
sequence identity between human and mouse (Fig S3C), containing multiple conserved transcription factor 182 
binding motifs (Table S3), including motifs for the important pancreas developmental regulators Nkx2.2 and 183 
Pax4 (8, 37). Furthermore, gene expression analysis showed that 19 out of 28 transcription factors with 184 
putative recognition motifs in the element are expressed in adult pancreas (Table S3) and indicate that PE4 185 
is a more pancreas specific element than PE3.  186 
Cis-regulatory elements that are expected to have a major role in common disease phenotypes are likely to 187 
harbour common variants within the population that could modulate their regulatory activity. To address 188 
whether any of the common SNPs found in PE3 and PE4 could disrupt transcription factor binding we 189 
scanned the human elements for SNPs embedded within transcription factor motifs. PE3 harbours two SNPs 190 
rs11031498 and rs11031499 but these did not coincide with any transcription factor binding sites. In 191 
contrast, rs7943160G>C within PE4, is a common variant in the population (Fig S4) which overlapped three 192 
transcription factor binding motifs: KAISO, MZF1 and Pax4 (Table S3).  193 
A common variant in PE4 alters regulatory element reporter activity  194 
Pax4, an important regulator of pancreatic development, is expressed in adult α and β-islet cells (10). As 195 
PAX4 has been linked to both T1D, T2D (9, 11) and islet function we investigated variants in its binding 196 
motif in PE4. SNP rs7943160 altered position 29 of the 30 bp PAX4 motif (MA0068.1) (Figure 3B), with the 197 
motif having a stronger match for the ancestral C base over the common G variant. Multi-species sequence 198 
conservation analysis of PE4 revealed the PAX4 motif was seen across 59 mammals, with strong conservation 199 
of a C base in the aligned position of interest (94.8% of species) (Figure S5).  This suggested it is an important 200 
nucleotide position and thus a candidate for a common genetic variant that would alter PE4 regulatory 201 
function and PAX6 expression. To evaluate PAX4 binding to PE4 β-TC3 cells were transfected with a FLAG 202 
tagged version of human PAX4 (Fig 3C); FLAG-PAX4 ChIP signal over mouse PE4 was highly enriched 203 
compared to control regions (Figure 3D), so demonstrated that PAX4 can bind to the PE4 element.  204 
As the PAX4 motif in PE4 contains a variant that may alter PAX4 binding affinity, the effect of the 205 
rs7943160G>C variant on the activity of the human PE4 element was assessed using a dual luciferase reporter 206 
assay in β-TC3 cells. The conserved region of the human PE4 element, with either the rs7943160 G or C 207 
variant, was cloned upstream of a minimal promoter driving luciferase (Fig 3E) and transfected into β-TC3 208 
cells. Both variants of the PE4 element showed a decrease in luciferase signal compared to the empty vector, 209 
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demonstrating repressive behaviour. Importantly there was a striking and significant change in luciferase 210 
signal between the PE4(G) and PE4(C) variants (p < 0.001). To assess the effect of PAX4 on the variant 211 
binding sites, human PAX4 cDNA was co-expressed with luciferase constructs in β-TC3 cells (Fig 3E). As 212 
PAX4 is a transcriptional repressor of pancreatic genes (38), based on the predicted effect of the variants on 213 
the strength of the PAX4 motif in silico (Fig 3A), we hypothesized that the G variant element would have 214 
lower binding affinity for PAX4 resulting in decreased repression and an increased luciferase signal. Both 215 
PE4 variants showed more repression when PAX4 cDNA was co-expressed and there was a significant 216 
difference between the two alleles (p < 0.0001), which was exaggerated compared to non-PAX4 cDNA 217 
transfected samples (Fig 3E). Together this indicated that a common regulatory variant in PE4 can alter 218 
regulatory element function and PAX6 gene expression. 219 
Chromosome conformation capture reveals PE3 and PE4 regulatory looping to Pax6 220 
Looping interactions have been proposed as a mechanism for regulatory elements located 10-100 kb’s from 221 
target sites to interact and influence gene activity.  Previously chromosome conformation capture (3C)-222 
qPCR has been used to analyse interactions at multiple loci, so we selected this approach for characterising 223 
regulatory interactions around Pax6 from the PE3 and PE4 elements. We first investigated PE3 as it binds 224 
CTCF (Fig S3C) and CTCF’s role in coordinating gene regulatory looping is well established (36). PE3 was 225 
used as an anchor site from where relative interaction frequency was assayed at regular intervals across a 226 
panel of primers covering the 74 kb genomic landscape from PE3 to the Pax6 gene. The PE3 element showed 227 
increased cross-linking frequency over the TSS of the Paupar lncRNA, whilst the signal increased further at 228 
47 kb away from the anchor, over a region of high H3K27ac upstream of the promoter (Figure 1B), at the 229 
location of two known pancreatic regulatory elements P/EE and PE2 and then peaked over the Pax6 P0 and 230 
P1 promoter fragments (Fig 4A). This data showed that PE3 is a regulatory element which sits in spatial 231 
proximity to active Pax6 promoters in β-TC3 cells. The binding of pluripotency transcription factors at both 232 
the PE3 enhancer and promoter may facilitate Pax6 being maintained in a poised state (39). As such, we 233 
hypothesised that the PE3 element would be important for initial Pax6 gene activation, and maybe involved 234 
in priming the gene for subsequent expression in specific embryonic lineages such as neuroectoderm. 235 
Consistently 3C-qPCR in mouse embryonic stem cells revealed a more discrete interaction profile with signal 236 
peaking over background 3 kb upstream of the P0/P1 Pax6 promoter, but reduced compared to that seen in 237 
β-TC3 cells (Fig 4A). 238 
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We next hypothesized that PE4 would interact with the Pax6 promoter and gene body and these interactions 239 
would be detectably higher than in mESC cells where the element is not marked as active by H3K27ac. As 240 
predicted β-TC3 cells showed a complex profile with substantially higher relative crosslinking at both PE3 241 
and multiple regions of the Pax6 gene promoters and gene body than in mESC (Fig 4B), though the mESC 242 
sample did show increased signal over the PE3 and Pax6 gene, suggesting the whole locus maybe in a 243 
conformation permissive for further activation. In both β-TC3 and mESC PE4 relative crosslinking 244 
frequency was higher over a broad region encompassing the E-55 and PE3 elements (Fig4B), consistent with 245 
this region being H3K27ac positive in mESC and β-TC3 cells (Fig1B, 2A). Interesting the two elements 246 
showed very distinct interaction patterns to the Pax6 promoter indicating that regulatory elements have a 247 
high degree of specificity for targeting associations between specific regulatory regions. 248 
Recruitment of synthetic transcription factors to PE3 and PE4 regulates gene transcription 249 
Characterization of cis regulatory elements outside of the native genomic environment can only provide an 250 
incomplete picture of their function. TAL (transcription activator-like) effectors are a class of proteins that 251 
have been used to modulate transcription, epigenetic states (40, 41) and nuclear organisation (42, 43). As 252 
regulatory elements are landing pads for transcription factor binding, which transfer signals and factors onto 253 
gene promoter sequences, we reasoned that targeting a regulatory elements with a transactivator could be a 254 
useful approach to understand its specificity and behaviour. To examine the ability of the PE3 and PE4 255 
elements to influence native Pax6 expression we used a synthetic transcription factor modulation system 256 
(Figure 5A) using TAL effectors targeted to cis regulatory elements coupled to either a VP64 transcriptional 257 
co-activator (42) or a SID4X transcriptional repressor (40, 44) (Figure S3A,C). We reasoned that 258 
transcriptional modulation by synthetic transcription factor recruitment at the distal regulatory sites would 259 
affect Pax6 transcription if the elements were bona fide cis regulatory elements for the gene.  260 
As the PE3 element is a site for Sox2 and Oct4 binding (Fig 3A) TAL effector constructs were tested in 261 
mESC. Constructs were transfected into cells, enriched and RNA purified for qRT-PCR. TAL-VP64 262 
targetted to PE3 caused a significant 1.6 to 2 fold increase in Pax6 expression (Fig 5B) whilst expression of 263 
the TAL-SID4X (Fig 5A) repressor promoted a similar reduction in Pax6 expression. The neighbouring 264 
genes Elp4 and Immpl1 (~235 kb downstream from Pax6 promoter) showed an increase in expression whilst 265 
the upstream gene Rcn1 (~270 kb away) showed no significant change in expression, nor did the control 266 
Oct4 gene (Fig 5B). In contrast SID4X recruitment reduced expression of both the Pax6 and Rcn1 genes.  267 
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To test the activity of the PE3 and PE4 elements in a pancreatic environment, constructs were expressed in 268 
β-TC3 cells. qRT-PCR for Pax6 revealed significant transcriptional upregulation (2.5 to 3.4 fold) (Figure 6C) 269 
after VP64 recruitment, demonstrating PE4 can act over 120 kb to affect Pax6 expression.  As the H3K27ac 270 
signal in β-TC3 cells (Figure 1B) extends ~8 kb upstream of the P0 promoter over the lnRNA Paupar (45), 271 
we hypothesised that Paupar might be active in β-TC3 and modulated by factor recruitment to PE4. Paupar 272 
was indeed expressed to a similar level as Pax6 and showed a strong and significant four-fold increase in 273 
expression upon VP64 recruitment (Fig 6B). As for mESC neighbouring genes were also influenced by VP64 274 
recruitment, particularly downstream of the gene, consistent with promoters interacting locally with each 275 
other (46), but suggesting that Rcn1 might be too far away to be strongly influenced by Pax6 elements. SID4X 276 
recruitment did not have the repressive effect on gene expression seen in mESC, but surprisingly induced a 277 
small increase in expression at Pax6, Paupar and Immpl1. VP64 recruitment to PE3 had an even greater 278 
effect on Paupar expression than PE4 activation (Fig 5D) so we speculated that PE3 and PE4 function might 279 
be conserved in human pancreatic beta cells and regulate Paupar lncRNA in a similar manner.  280 
To further investigate the co-expression of Pax6 with surrounding genes the correlation between gene 281 
expression across 23 RNA-seq samples in mouse tissues and cell lines (Fig S6A) was analysed. Pax6 282 
expression was well correlated to downstream neighbouring genes, Pax6Os1 (0.73) and Elp4 (0.53), and 283 
showed little or a negative correlation with genes further upstream, Rcn1 (0.004) and Wt1 (-0.73). 284 
Consistently Pax6 is in a shared topologically associated domain (TAD) with surrounding genes as seen by 285 
HiC data visualisation in mESC (Fig S6B). 286 
Discussion 287 
The Pax6 locus has a densely packed regulatory landscape with more than 15 distinct regions of regulatory 288 
activity and many more predicted sites.  Using complementary approaches, we identified two novel Pax6 289 
regulatory elements that are conserved in sequence and function between human and mouse. These novel 290 
elements drive diverse tissue specific developmental expression patterns, at multiple stages of mouse 291 
development, and act as key signal input sites for gene expression modulation in pancreatic and embryonic 292 
stem cells.  293 
Transcription factor binding is a critical property of regulatory elements; multiple putative binding sites 294 
including CTCF and Pax4 were identified and characterised at PE3 and PE4, respectively (Fig S3), along with 295 
components of the ESC transcription factor network, Sox2, Oct4 and Nanog, (Fig 2A). CTCF is often 296 
Downloaded from https://academic.oup.com/hmg/advance-article-abstract/doi/10.1093/hmg/ddy255/5052132
by Edinburgh University user
on 16 July 2018
  12
considered as a chromatin looping factor; consistent with this we showed PE3 interacted with the Pax6 297 
promoter region in mESC.  We propose that PE3 also has a role in recruiting the transcriptional apparatus 298 
to Pax6 in differentiated β-TC3 pancreatic cells, and maybe an element important for general Pax6 gene 299 
activation in multiple tissues including the pancreas, consistent with its broad developmental expression 300 
pattern (Fig 2).  Recruitment of preinitiation complex components to distal elements has been described at 301 
early stages of transcription at globin genes (47, 48), and likely facilitates efficient transfer of factors ready 302 
for later differentiation. Using synthetic transcription factors we confirmed that PE3 can transfer both 303 
activator and repressive signals over more than 45 kb to modulate Pax6 gene expression. Interestingly we 304 
were able to repress Pax6 gene expression in mESC via TAL recruitment, but not β-TC3 cells using SID4X, 305 
this could be due to the mechanism of action of the Sin3 domain, which likely acts via Hdac1/2 and histone 306 
deacetylation (49). The correct combinations of factors may not be bound or available in β-TC3 cells or the 307 
factors involved in transcriptional activation may override these signals. ESC transcription may also be more 308 
plastic and more easily modulated; early establishment of enhancer activity and a poised bivalent gene 309 
expression state in ESC is proposed as a means of efficient activation of target genes on differentiation, and 310 
bivalent marks are focused on homeodomain transcription factors such as Pax6 (39). This is supported by 311 
Sox2 binding to neural lineage-specific genes in advance of gene expression, which are then activated during 312 
differentiation (50). We propose that early activation via regulatory looping of PE3 (Fig 4A), may transfer 313 
ESC transcription signals which can specify ESC identity (39) and likely poises Pax6 for rapid activation as a 314 
transcription factor in neural differentiation.  315 
The PE4 element has a more tissue restricted expression pattern than PE3 (Fig 2), and in a pancreatic cell 316 
line model PE4 was regulated by the well-characterised pancreatic regulator, PAX4, through direct binding 317 
to the element (Fig 3). Furthermore, the human PE4 element encodes a single nucleotide common variant 318 
in a conserved PAX4 motif (Fig 3B), which modulates its reporter activity in a PAX4 dependent manner. 319 
This demonstrates that a PAX4/Pax6 regulatory network can be modulated by sequence variants found in 320 
the population (Fig S4). Both PAX4 and PAX6 have a well-established link to diabetes phenotypes (9, 12, 13, 321 
17). PAX4 is linked to the susceptibility of β-cells to apoptosis, leading to diabetes (9) and is found to be 322 
significantly differentially expressed within a T2D cohort of adult islets (10). Similarly, mutations in a 323 
number of transcription factors for islet function including PAX4, PAX6 (3), HNF1 A(51), Nkx2.2 (52) , and 324 
SOX4 (53), cause diabetes or diabetes-like phenotypes in human and mouse. Unsurprisingly genome-wide 325 
association studies for T2D are now revealing common variants at islet transcription factor loci (54). Pax6 326 
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regulates multiple β-cell specific genes (insulin 1 & 2, Pdx1, GLUT2, Nkx6.1) (7), so subtle dysregulation of 327 
a master regulator may cascade through transcriptional networks to cause downstream phenotypic effects. 328 
Such a scenario fits with a study suggesting a link between sequence variation in pancreatic islet cell 329 
enhancers and T2D (18). Therefore, the identified functional variant in the PE4 element might play a role in 330 
modulating gene function and contribute to tissue specific human phenotypic variation. As Pax6 expression 331 
in the adult pancreas has been shown to be important for islet maintenance and function we propose a model 332 
where subtle variations in the tight regulation of Pax6, via a cis-regulatory mechanism, interact with other 333 
genetic and environmental risk factors to affect T2D disease risk. 334 
Synthetic transcription factor recruitment to a cis regulatory elements is an important tool to test and 335 
functionally dissect element activity and specificity. Using synthetic transcription factors (Fig 5) we showed 336 
that PE3 and PE4 could regulate Pax6 expression in pancreatic β-TC3 cells. We also found TAL recruitment 337 
influenced neighbouring gene expression to suggest a complex interplay between locally interacting or 338 
regulating genes. This could be directly through shared element interactions with neighbouring genes in the 339 
same TAD or via gene clustering in a hub influencing one another’s expression (55).  This questions the idea 340 
of regulatory elements controlling single target genes and is consistent with experiments using the sleeping 341 
beauty transposon as a regulatory sensor which shows much of the genomic region around target genes are 342 
permissive to regulatory signals (56). 343 
The Pauper lncRNA was upregulated by VP64 recruitment to PE3 and PE4 elements, this combined with 344 
interaction data that showed high relative crosslinking frequency over the Pauper gene indicates it is a target 345 
of these elements. Pauper was previously identified as a CNS specific lncRNA expressed from the Pax6 locus, 346 
that was able to bind multiple regulatory elements in cis and trans, and  linked to intraocular tumours (45, 347 
57). Using shRNA mediated downregulation of Paupar, Vance et al. (45) showed it could transcriptionally 348 
regulate Pax6, whilst Pax6 knockdown did not affect Paupar levels, suggesting the mechanism was not via a 349 
Pax6 auto-regulatory affect. Our data indicates that Pax6 and Paupar are coupled at the level of 350 
transcription, potentially via shared elements or linked promoter activity. In a recent study of human 351 
pancreatic β-cell lnRNAs, Akerman et al. (58) found cell type specific lnRNAs play an important role in 352 
transcriptional regulation of multiple important pancreatic transcription factors acting both in cis and in 353 
trans, and were significantly altered in type 2 diabetic donor islets. Of particular interest the downregulation 354 
of the lnRNA neighboring the PDX1 transcription factor gene, PLUTO, altered 3D enhancer interactions 355 
with PDX1, and could suggest a shared mechanism of cis-regulator function with Paupar/Pax6. Our data 356 
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reveals complex patterns of transcription factors and binding motifs at novel pancreatic cis-regulatory 357 
elements. These tune tissue-specific PAX6 gene expression, can be modulated by common genetic variants, 358 
and further implicate the Pax6 locus in pancreas function and diabetes. 359 
  360 
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Materials and Methods 361 
Cell lines 362 
β-TC3 cells were isolated from a mouse insulinoma (27) and  were cultured in Dulbecco’s Modified Eagle 363 
Medium (ThermoFisher) supplemented with 10% fetal calf serum and 1% Penicillin-Streptomycin at 37°C 364 
in 5% CO2.  Mouse OS25 embryonic stem cells where cultured in Glasgow's MEM (ThermoFisher) 365 
supplemented with 10% fetal calf serum, 1% Penicillin-Streptomycin, 1% MEM Non-essential Amino Acid 366 
Solution (Sigma), 1mM Sodium Pyruvate (Sigma), recombinant LIF and 0.01 mM 2-Mercaptoethanol 367 
(Gibco), at 37°C in 5% CO2 using standard techniques. 368 
 369 
Chromatin Immuno-precipitation 370 
H3K27ac (Abcam, ab4729) or CTCF ChIP (Cell signaling, D31H2 XP Rabbit mAb #3418) was performed as 371 
described previously (19) using Protein G Dyna beads (ThermoFisher Cat#10003D) with two biological 372 
replicates. Primers where designed using Primer3 to PE3 regions with flanking control primers (List of 373 
primers). QPCR was performed using LightCycler® 480 SYBR Green I Master Mix (Roche Cat#04707516001) 374 
according to the manufacture’s guidelines and using a LightCycler® 480 II, with primers at a final 375 
concentration of 0.5 μM.  Ct values were used to calculate ChIP enrichment at each primer region vs 10% of 376 
Input DNA. 377 
 378 
H3K27ac ChIPs were validated by qPCR before hybridisation to genomic microarrays (Nimblegen 720K) 379 
covering a 66 Mb region around Pax6 (Chr2:75,000,000-141,000,000). ChIP and Input samples where 380 
amplified (GenomePlex, Sigma), purified (QIAquick, Qiagen) and labelled (NimbleGen Dual-Colour 381 
Labelling Kit, Roche Cat. 06370250001). ChIP samples (Cy5) and Input samples (Cy3) were hybridized using 382 
a NimbleGen Hybridization and Sample Tracking Control Kit (Roche Cat. 05993776001) according to the 383 
manufacturer’s instructions. Slides were washed (NimbleGen Wash Buffer Kit, Roche Cat. 0558450700) and 384 
scanned at 2 μm resolution on a MS 200 Microarray Scanner (Nimblegen). Images were processed using 385 
NimbleScan (version 2.5); Ringo (Bioconductor) was used for pre-processing, normalisation, combining 386 
replicates and peak calling of ChIP-chip data. Data was further processed in R by applying a running median 387 
(500 bp) and visualised on the UCSC genome browser. 388 
 389 
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Human PAX4 cDNA (Transgenomics) was PCR amplified (Supplementary Table 5) and cloned into 390 
pcDNA5/FRT/TO/3xFlag with HindIII/XhoI. pcDNA5/FRT/TO3xFLAG was generated by ligating 3xFLAG 391 
(amplified from  p3xFLAG-CMV-10(SIGMA); List of primers) into pcDNA5/FRT/TO at AflII/BamHI. 392 
PAX4-FLAG ChIP was performed as described as above with the following modifications. β-TC3 cells were 393 
transfected using Lipofectamine 2000 according to the manufacturer’s protocol (Thermo Fisher) in Opti-394 
MEM, using 12 μg of PAX4-FLAG construct per 10 cm dish and cells were harvested after 48 h. IPs were 395 
performed using mouse monoclonal anti-FLAG M2 (Sigma), Mouse IgG as control, and Sheep anti-Mouse 396 
IgG M-280 Dynabeads (Thermo Fisher). QPCR was performed on ChIP material with SYBR Select Master 397 
Mix (Thermo Fisher Cat# 4472908) on a LightCycler 480 II, standard protocol. To quantify ChIP enrichment 398 
primers were designed to the mouse PE4 element and control regions (List of primers), and enrichment 399 
calculated % Input. 400 
 401 
Luciferase reporter assays 402 
β-TC3 cells were grown overnight in a 24 well culture plate. Cells were transfected with luciferase reporter 403 
constructs (as described below), human PAX4 or PAX6 cDNA (Transgenomics), and with Renilla luciferase 404 
pRL-TK (Promega) as an internal control. Luciferase assays were performed 48 h after transfection using a 405 
Dual-Luciferase Reporter Assay System (Promega). Relative luciferase activity was calculated by dividing 406 
Firefly Luciferase signal by Renilla Luciferase signal and normalising the resulting value to the relative 407 
luciferase activity of the negative control vector. Five biological replicates of each assay were performed. To 408 
analyse expression of PAX4, PAX6 and FLAG tagged constructs cell extracts were prepared in 4 x LDS 409 
sample buffer and analysed by protein gel electrophoresis (NuPage, Invitrogen) and Western blotting with 410 
anti-PAX4 (Abcam,135598), anti-PAX6 (AD1.5.6 and AD2.35) (59), anti-hnRNPU (Millipore, 05-1516) and 411 
anti-FLAG M2 (Sigma) primary antibodies. Luciferase reporter constructs were made by cloning the 412 
putative PE4 element (Chr11:31947517-31948318) into a minimal promoter pGL4.23 vector (Promega). 413 
Single base pair changes corresponding to the SNP variants were introduced into the putative PAX4 motif 414 
within the PE4 element by site directed mutagenesis using a mega-primer approach and confirmed by 415 
sequencing. 416 
 417 
Mouse Reporter transgenics 418 
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Mouse LacZ reporter transgenics were derived as described previously (4). Three founders were obtained 419 
for the PE3 element (chr2:105456479 -105456966), two of which showed an expression pattern consistent 420 
with previously obtained transiently expressing embryos. Line PE3Z-004 was selected as representative and 421 
multiple embryos from PE3Z-004 male x wild type female matings were analysed at three developmental 422 
stages; E10.5, E11.5, and E17.5. Two stable LacZ lines were established for the PE4 element (chr2:105390725-423 
105393222; PE4-Z-011 and PE4-Z-029) and representative embryos were analysed at three developmental 424 
stages, as above. All animal experiments were approved by the University of Edinburgh ethical committee 425 
(approval ID TR-15-08) and performed under UK Home Office license number PPL 60/3785. 426 
 427 
RNA-seq  428 
Two experimental replicates where generated with two T25 culture flask of β-TC3 cultured to ~70% 429 
confluency. Total RNA was prepared using the Qiagen RNeasy mini kit (Qiagen) with an on-column DNase 430 
I digestion using the Qiagen RNase-Free DNase set as the manufactures guidelines. Ribosomal RNA 431 
depletion was performed using the RiboMinus Eukaryote Kit for RNA-Seq (Life Technology) and RiboMinus 432 
Concentration module as manufactures’ guidelines, with ribosomal depletion was confirmed by gel 433 
electrophoresis. Sequencing libraries where prepared using NEBNext mRNA Library Prep Master Mix Set 434 
(NEB), following the manufactures protocol, with all size selection performed using Agencourt AMPure XP 435 
beads (Beckman Cutler). Samples where multiplexed suing the NEBNext Multiplex Oligos for Illumina kit 436 
to barcode each sample and amplified for 11 cycles. The libraries were analysed using an Agilent bioanalyser 437 
high sensitivity DNA chip. The subsequent samples were processed by the Next Gen Sequencing facility at 438 
the VU University Medical Centre, Department of Pathology Amsterdam, using an Illumina Hi-Seq 2000 439 
producing single end 50 reads. Reads where aligned to mm9 geneome index using TopHat v2[67] and 440 
processed with Samtools v1.6 .  Ethical approval was received to re-analayais RNA-seq data from 6 primary 441 
human β-Cells from Nica et al 2013. For both human and mouse samples aligned bam files where processed 442 
with Subread v1.5 feature counts to generate FPKM scores (using total number of aligned of reads and gene 443 
length) against hg19 and mm9 RefSeq genes (60). Bedtools genome coverage tool (61) scaled to number of 444 
aligned reads was used to generate visualization of read distribution across the human and mouse Pax6 locus. 445 
 446 
Bioinformatic data and analysis 447 
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All genomic positions are hg19 or mm9. Primary human histone modification ChIP-seq data was 448 
downloaded from the Human Epigenome Atlas (Table S4). Peak calling was performed using MACS version 449 
1.4.2, P value cut off 0.005 (62).  Conserved transcription factor binding sites within aligned human and 450 
mouse sequences where identified with rVista (30). Human-mouse sequence alignment was performed using 451 
Clustal Omega. Candidate transcription factor motifs altered by SNPs were identified using HaploReg and 452 
motifs were validated using the Jasper database (63, 64). Spearmen correlation on neighbouring gene 453 
expression was performed in R using RNA-seq RPKM values from 23 mouse tissue and cell line data sets, 20 454 
samples from (65), differentiated neurons from (50), and β-TC3 cell RNA-seq, were analysed with Geneprof 455 
tool (66), (see Table S4 for details of 23 mouse samples). 456 
 457 
3C-qPCR 458 
The 3C procedure was based on the methods adapted from (67). A none ligase control sample were run 459 
alongside experimental samples, and produced no enrichment in qPCR assays. Adherent β-TC3 and OS25 460 
mESC were treated with trypsin/versene and resuspended as a single cell suspension in 10% FCS/PBS. Cells 461 
were counted and 1x107 cells were used per 3C experiment.  Cells were fixed in 10% FCS/PBS with 2% (v/v) 462 
formaldehyde (Sigma) for 10 min at room temperature. Glycine was added, cells centrifuged and lysed in cell 463 
lysis buffer [10 mM Tris-HCl, ph 7.5; 10 mM NaCl; 0.2% (v/v) Ipegal, PI]. Cells were centrifuged and 464 
resuspened in 500 μl 1.2x NEB 3. 3C samples were incubated with SDS at a final concentration of 0.2% for 1 465 
h, before Triton X-100 was added to 2% for 1 h. 1000 U of concentrated BglII restriction enzyme (NEB Cat# 466 
R0144M) was added for overnight digestion at 37°C and 1200 rpm. Digestion efficiency was analysed on 5 μl 467 
pre and post digested template by gel electrophoresis. Restriction enzyme was deactivated by heating at 65°C 468 
for 25 min in 1.6% SDS. Ligation of 3C library was performed in a final volume of 7mls diluted in 1x T4 DNA 469 
ligase reaction buffer (NEB), with 1% Triton X-100. Ligation was performed at 16°C for 4 h at 300 rpm with 470 
3.3 μl of high concentration DNA ligase (NEB Cat#M0202M). Cross-links were removed by heating at 65°C 471 
overnight with 300 μg of PK, followed by incubation at 37°C for 1 h with 300 μg RNase A. Samples were 472 
purified by two sequential phenol-chloroform extractions (Sigma), ethanol precipitation, resuspended in 150 473 
μl of 10 mM Tris pH7.5. 474 
  475 
The PE3 and PE4 anchor fragment primers where designed with both primer and probe to lie within 150 bp 476 
of the BglII cut site. The probes where dual labelled with a 5’ 6-FAM fluorophore and a 3’ BHQ1 quencher.  477 
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The variable fragment primer panel (primer list) were designed to lie within 100-150 bp of the target BglII 478 
restriction site using an in silico digest of the mouse genome across the Pax6 regions (mm9 build). The panel 479 
of variable fragment primers was validated on a random ligation template (RLT, design below) using the 480 
anchor primers and constant probe primer to confirm each primer and probe efficiency across a range of 481 
DNA concentrations. 482 
 483 
BAC DNA for the Pax6 locus (RP23-281P3, Chr2: 105,427,870-105,581,806) and PAC for the control Ercc3 484 
region (PAC 334G18) where used to generate a RLT for the region of interest, to produce values of the 485 
standard curves for each primer combination. BAC and PAC DNA was prepared used a standard alkaline 486 
lysis mini-prep method. The RLT was prepared (68), with equimolar amounts of BAC and PAC DNA 487 
digested with BglII as for the 3C protocol, phenol chloroform extracted, and precipitated. The DNA was 488 
ligated at high DNA concentrations to promote intra-molecular ligation events and purified. Standard curves 489 
were generated using the RLT on the primer panel as described by (68), with serial 5-fold dilutions of RLT 490 
used to produce standard curves for all variable primers with the probe and constant fragment primer.  491 
Digested and ligated genomic DNA was used to keep the sample DNA concentration in the qPCR reaction 492 
constant and the probe qPCR protocol was performed as 3C samples qPCR.  Absolute quantification was 493 
performed using a LightCycler 480 II (Roche) using LightCycler 480 software to generate the standard curve 494 
efficiency, slope and intercept values. Four qPCR reactions were performed for each primer sample 495 
combination, using QuantiTect Probe PCR master mix standard protocol (Qiagen Cat#204341), the probe 496 
at a final concentration of 0.15 μM and primers at 0.5 μM, the LightCycler480 program described in Hagège 497 
et al. (67), detecting 6-FAM signal. Two independent biological experiments were performed each 498 
generating individual Ct values and calculations were performed as in (67) with each Ct value used to 499 
calculate a relative cross-linking frequency using the parameters of the standard curve, and then normalised 500 
to Ercc3 background interactions to allow comparison between samples. The final relative cross-linking and 501 
SEM calculation was performed on the mean relative cross-linking across both experimental replicates and 502 
this was plotted as a function of the distance from the anchor probe to the test primer. 503 
 504 
TALEs 505 
TAL (transcription activator-like) effectors (TALEs) were assembled using a modular assemble system ) (41) 506 
in which specific RVD DNA binding domain is constructed through assemble of  three 4-mer modules and 507 
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one-3mer plasmid module, linearized with BsmBI and cloned into pTAL-VP64-eGFP(42). The PE3 and PE4 508 
regulatory element target sequence where identified using the TAL effector nucleotide targeter 2.0 tool (69), 509 
and were targeted to a 16bp sequence in the core element sequence (PE4_TAL: TCCTCAGGCCATGCAT, 510 
chr2:105392464-105392479; PE3_TAL: TCGAGCTAATCCTCTT, chr2:105456674-105456689). To 511 
generate SID4X TALEs the VP64 sequence was removed using (BamH1/Nhe1 digestion) and replaced with 512 
the SID4X sequence (see primers).  513 
Mouse ES and β-TC3 cells where seed at ~70-80% confluency in 60 mm cell culture dishes 24hr before 514 
transfection and transfected in Opti-MEM with Lipofectamine 3000 (ThermoFisher) using a standard 515 
protocol with 5 μg of plasmid, and incubated for 48hours (β-TC3) and 36hours (mESC) . Cells where washed 516 
in PBS, trypsinized and flow sorted for eGFP expression and GFP positive cells collected. Flow sorting was 517 
performed on a BD FACSAria2 SORP cell sorter by MRC HGU FACS facility, GFP data was collected using 518 
a 488nm excitation laser and a 525/50nm bandpass emission filter, and BDFACS Diva software version 6.1.3 519 
was used for data collection. GFP positive cells were collected and RNA extracted using a RNeasy mini Kit 520 
(Qiagen), with GFP negative mock transfected cells as control, all RNA samples were digested with DNaseI 521 
on column (Qiagen). RNA concentration was measured and corrected for all samples and reverse 522 
transcribed to cDNA using SuperScript III (ThermoFisher) using a standard first strand synthesis protocol 523 
with Oligo(dT) primers (Promega), for two biological replicates. Real time qPCR was used to measure 524 
transcript levels using a LightCycler 480 II (Roche), with SYBR Select Master Mix (ThermoFisher) following 525 
the manufacturer protocol with primers at 0.5 μM.  Gene specific primers were designed to Ensemble cDNA 526 
transcripts (List of primers), we were unable to design primers which could assay Pax6OS1.  The log2 fold 527 
change calculated using the ΔΔCT method against mock transfection controls, with 18S as a housekeeping 528 
gene. 529 
List of Primers 530 
Pax4 ChIP qPCR 531 
ChrX_Con TTCTGGGGTTTGTGCATGTG(f) AGAGTAGAAGGACGGTATTGGT(r) 532 
PE4_1  TAGCCGGTGTTCCATTGTCT(f) GCTAGTGTTTAAACCGCTCCA(r) 533 
PE4_2  GCCAACCAGACAATCTTCAGT(f) GCTGGGCTGTAATTTGCTGA(r) 534 
PE4_3  GGAGCGGTTTAAACACTAGCA(f) GAGCTTCTCTGGCAGCCTT(r) 535 
PE4_Con  ATGTGCAGCTATCCCCATGT(f) TGTGGAATGCTCAGCCCTAA(r) 536 
Chr2_Con GTGGCACATCACAAATGCTC(f) TCTCCAGTCTAACACTTGGCAAT(r) 537 
CTCF ChIP qPCR 538 
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Hum.PE4.1 CGCTAGTTTCAATTTGGCTGT(f) TGAATAGCGGCAAAGATCCTG(r) 539 
Hum.PE4.2 TGAAGATACCTGGATGAAGCACT(f) TGTGAATGAATAGCGGCAAAGA(r) 540 
Luc.IP.1  TTCGACCGGGACAAAACCAT(f) ATCTGGTTGCCGAAGATGGG(r) 541 
Luc.IP.2  TTCGGCAACCAGATCATCCC(f) GTACATGAGCACGACCCGAA(r) 542 
PE3_1  CCAGTGCTCTGGGCTACAAT(f) AAGACGCCAGGAAGAGGATT(r) 543 
PE3_2  AATCCTCTTCCTGGCGTCTT(f) GGAAGGCTCTGTCCCTCTTT(r) 544 
Con_+1kb TGTTTTGGGGTCTCCTGAAG(f) CATGGACTAACAATGCTTCTCCT(r) 545 
Con_-1kb AAGAGGACTCAGCGAAACCA(f) TGACCTCATGCCAACTCATC(r) 546 
Taqman probes 547 
PE3_probe CCTCTTCTTTCACAGTGTTCCCTGA 548 
PE4_probe CCTGCCTTGAAAACTCTTCTCGTCTCTG 549 
Ercc3_probe  CCAGACCAGAGAGCGGAGACC 550 
3C primers 551 
3C_PE4.F GGTGAGTCTTTACATGTGGGG 552 
3C_1.F TCCCACCATCCAAATTCTGT 553 
3C_2.F GCCATCTCTCTAGCCCCTTT 554 
3C_3.F CCTCTTCTGTCCAGGCTTTG 555 
3C_PE3.F AGCAAATGTGTGACCGTGAG 556 
3C_4.F ATCCACCCACCTCCTTATCC 557 
3C_5.F CTCTTTCTGGTTTGCGGTAT 558 
3C_6.F CTGTTCTTCCTCTGAAACCTG 559 
3C_7.F ACAGTGGCACGTTGGATATG 560 
3C_8.F TGTGTGCAAATGAAGGCTCT 561 
3C_9.F TGACCTGCAAGAAGACACAGA 562 
3C_10.F CGCTTTGATTCTAGCCAGAC 563 
3C_11.F GTGTAATTGAGGGAAATGGAGTTGAA 564 
3C_12.F GGCCAGTTTGACACACCTTT 565 
3C_13.F CCCCAACCTTTGTACTCAGC 566 
3C_14.F TCTTTTGCCCAGAGATGAGC 567 
3C_15.F GGAAAGGCACTTGGAAATGA 568 
3C_16.F CTGGTGACCATCCACTCTCC 569 
3C_17.F TGAGAGGACCCATTATCCAGA  570 
3C_errc3_1.F     GGCTGAGAGTGATGCTGCTA 571 
3C_errc3_2.F CGGTAAATCTCCTCCCAAAT 572 
Cloning 573 
hPAX4  TCGCAAGCTTATGAACCAGCTTGGGG(f) TGCCCTCGAGTTATTCCAAGCCATACAG(r) 574 
3xFLAG  ACGACTTAAGGGCGCGCCACCATGGACTACAAAGACC(f) GTCAGGATCCTCTAGAGTCGAC(r) 575 
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SID4X  ACGAGGATCCGGCTCCGGGATGAACATCCAG(f) GTCAGCTAGCTCTACTGGGCAGCATAGAGG(r) 576 
TAL RT-qPCR  577 
Pax6 ex6-7 AGTTCTTCGCAACCTGGCTA(f) GTGTTCTCTCCCCCTCCTTC(r) 578 
Pax6 ex4-5 CGTGCGACATTTCCCGAATT(f) CTTGGCTTACTCCCTCCGAT(r) 579 
Paupar  TGCTCTTCTGTCTAGGGTGC(f) AACTTCATCCAAAAGGCCGG(r) 580 
Oct4  CGAGAACAATGAGAACCTTC(f) CCTTCTCTAGCCCAAGCTGAT(r) 581 
18s  GTAACCCGTTGAACCCCATT(f) CCATCCAATCGGTAGTAGCG(r) 582 
Immpl1.ex3_4 GCTTTTCGACTTGCTGGCTA(f) TGTCGGCTAAGATTTTCTGCA(r) 583 
Rcn1.ex2_3 AGAATACAAGCAGGCCACCT(f) GCAGAAAGGCAGTGAACTCC(r) 584 
Elp4.ex3_4 CATGGCAGAAGGAATCATCA(f) GCTCTGGGGTTTTAGCACTG(r) 585 
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Figure1. H3K27ac profiling identifies regulatory elements in the PAX6 locus. A. Diagram showing the 781 
human PAX6 regulatory domain with flanking genes. Genomic position of known PAX6 regulatory elements 782 
are marked in black (UCSC liftover from mouse coordinates) and sequence conservation (blue). B. Human 783 
PAX6 locus with ChIP-seq for H3K27ac histone modification (green) in primary pancreatic islet and small 784 
intestine tissue from Human Epigenome Atlas, with MACS identified peaks (62). RNA-seq feature counts 785 
(black) for representative human β-cell sample (25) (Table S1), and vertebrate conservation (blue). C. ChIP-786 
chip for H3K27ac histone modification in mouse β-TC3 cells (green), with called peaks. RNA-seq feature 787 
counts (black) for combined β-TC3 cell replicates. UCSC Refseq genes (orange) and known Pax6 regulatory 788 
elements. ChIP data represents average (n = 2). hg19 and mm9 coordinates. 789 
Figure 2. PE3 and PE4 cis regulatory elements drive neural and pancreatic expression in mouse 790 
embryos. Stable mouse line with PE3 reporters showed strong signal in Pax6 expressing tissues at E10.5 (A-791 
B), E11.5 (C-D) while PE4 showed a more restricted Pax6 expression pattern at E11.5 (E-F), E17.5 (G-H). A. 792 
Lateral view of E10.5 embryo showed LacZ staining in the ventral cerebral vesicles (cv) of the telencephalon, 793 
the ventral midbrain (mb), rhombencephalon (rc) and neural tube (nt). B. Transverse section through body 794 
of E10.5 embryo showed ventral (nt) staining in neurogenic region of the basal plate (bp), dorsal root 795 
ganglion (drg) and visible staining in the pancreas primoridum (pp). C. Lateral view of PE3 embryo at E11.5 796 
showed ventral forebrain expression (vf), staining in (mb), the (rc) into the (nt) and the developing eye (e). 797 
D. Transverse section through body of E11.5 embryo revealed strong ventral (nt) staining in the neurogenic 798 
region of the basal plate (bp) of the (nt), plus the dorsal root ganglion (drg) surrounding the (nt), and (pp) in 799 
the body cavity. E. Lateral view of E11.5 embryo with staining in the forebrain (fb), ventral (mb), rhombic lip 800 
(rl) of rhombencephalon (rc), neural tube (nt) and (e). F. Transverse section through the body showed diffuse 801 
ventral neural tube (vnt) staining, dorsal root ganglion (drg), sympathetic chain neurons (scn) below the 802 
neural tube, and (pp) staining in the body cavity. G. Dissected E17.5 pancreas (p) cut into two cross sections 803 
revealed internal staining pattern. H. Lateral view dissected E17.5 brain showed nerve tracts in the forebrain 804 
consisting of lateral olfactory tracts (lot) and ventral brain nuclei staining in cerebellum (cb) and hindbrain 805 
(hb). 806 
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Figure 3. Histone modification and transcription factor binding across PE3 at the Pax6 locus in mESC 807 
and characterization of a PE4 regulatory variant A. 100 kb genomic region surrounding the PE3 element 808 
at the Pax6 gene showing histone modifications and transcription factor binding in mESC (32). B. Position 809 
of putative regulatory SNP in Pax4 binding sequence, with motif and alignment score from Jaspar database 810 
(63). C. (left) Western blot analysis of β-TC3 cells transfected with FLAG-PAX4 or FLAG-hnRNPU with a 811 
mock transfection control, detected with an antibody against FLAG and using histone H3 antibody as a 812 
loading control. (right) Western blot analysis of β-TC3 cells transfected with untagged PAX6 or PAX4 813 
cDNAs and a mock transfection control, probed with antibodies against PAX4, PAX6 and hnRNPU as a 814 
loading control. D. ChIP assay for FLAG-PAX4 in β-TC3 cells, evaluated by qPCR, using primer sets to the 815 
mouse PE4 element. Top, Schematic showing primer locations, with negative control primers to a sequence 816 
4 kb upstream of PE4 (PE4_Con), intergenic regions on Chr2 (Chr2_con) and a large intron in Pola1 on 817 
HSAX (chrX_Con). Values are displayed as percentage of input sample, with two independent experimental 818 
replicates of FLAG-PAX4 ChIP. Error bars +/- SEM. E. Dual luciferase assay for human PE4 element 819 
encoding the G or C variant in pGL4.23 vector, transfected into β-TC3 cells, co-transfected with human 820 
PAX4 cDNA. Relative luciferase signal represents firefly luciferase over Renilla luciferase signal, normalised 821 
to the signal from the empty vector. Error bars +/-SEM, n=5; P value from Welch’s two sample t-test (p 822 
values: **** < 0.0001, *** < 0.001, ** < 0.01, * < 0.05). 823 
Figure 4. 3C-qPCR reveals PE3 and PE4 interaction with multiple regions over Pax6 gene. A. PE3 3C-824 
qPCR data displayed as relative cross-linking frequencies between the PE3 anchor fragment and BglII 825 
fragment primers across the mouse Pax6 locus in β-TC3 and mESC. B. PE4 3C-qPCR data from the PE4 826 
anchor fragments in β-TC3 and mESCs.  Data sets are scaled to one another and display genomic position 827 
relative to 3C primer values. Data from the two cell lines were normalised using a probe located in the Ercc3 828 
locus. Signal is the combined mean relative cross-linking frequency of 6-8 individual qPCR values, across 2 829 
experimental replicates. Error bars +/-SEM.  830 
Figure 5. TALE recruitment to regulatory elements can modulate target gene expression. A. Schematic 831 
showing TAL effector proteins designed to PE3 and PE4 regulatory elements fused to activator VP64 or 832 
repressor SID4X domains, with co-expressed GFP. Position of PE3 and PE4 TAL effectors with respect to 833 
CTCF and PAX4 binding sites. B-D. Graph showing relative change in Pax6, Paupar, Elp4, Immpl1 and 834 
Rcn1 and Oct4 expression after transfection with TAL effectors fused to VP64 or SID4X targeted to the PE3 835 
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or PE4 regulatory elements in β-TC3 or mESC. RNA levels were quantified by RT-PCR and normalised to 836 
18S RNA. Error bars +/-SEM, n=2. P value from a Welch t-test of ΔCT values (p values: **** < 0.0001, *** < 837 
0.001, ** < 0.01, * < 0.05). 838 
Abbreviations 839 
(BMI) Body Mass Index  840 
(3C) chromosome conformation capture 841 
(CNS) central nervous system  842 
(DRR) downstream regulatory region 843 
(ESC) mouse embryonic stem cells 844 
(lncRNAs) long noncoding RNAs  845 
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